.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
UBS
McKinsey
Boehringer Ingelheim
Johnson and Johnson
Accenture
Dow
Cipla
US Army
Queensland Health

Generated: December 13, 2017

DrugPatentWatch Database Preview

AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Aminophylline In Sodium Chloride 0.45% In Plastic Container, and when can generic versions of Aminophylline In Sodium Chloride 0.45% In Plastic Container launch?

Aminophylline In Sodium Chloride 0.45% In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is aminophylline. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminophylline profile page.

Summary for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

Drug patent expirations by year for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

Medical Subject Heading (MeSH) Categories for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
HospiraAMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERaminophyllineINJECTABLE;INJECTION018924-001Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraAMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERaminophyllineINJECTABLE;INJECTION018924-004Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraAMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERaminophyllineINJECTABLE;INJECTION018924-002Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraAMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERaminophyllineINJECTABLE;INJECTION018924-003Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Novartis
McKinsey
UBS
Harvard Business School
Fish and Richardson
Cipla
Argus Health
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot